Prostate cancer
Conditions
Interventions
Gold Standard:1.The pathological results of surgery or biopsy confirm prostate cancer, which is positive
2.If the patient has not undergone surgery or biopsy, imaging follow-up will be conducted. If the lesion increases or increases during follow-up for more than six months, it will be considered positiv
3.If the patient receives anti-tumor treatment and the lesion shrinks or disappears during follow-up, it is considered positive.
Index test:PET/CT imaging diagnosis of 68Ga-PSMA-11 and 18F-PSMA-1007
Sponsors
Hubei Cancer Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1.Voluntary signing of informed consent form; 2.Suspected prostate cancer patient; 3.Diagnosed as a patient with prostate cancer.
Exclusion criteria
Exclusion criteria: 1.Critically ill emergency patients with respiratory depression, (lung) airway obstruction, or tissue hypoxia; 2.Drug and/or alcohol abusers, allergic individuals; 3.Individuals who cannot tolerate and cooperate with the examination; 4.According to the judgment of the researcher, it is deemed unsuitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity and specificity of 68Ga-PSMA-11 and 18F-PSMA-1007 PET/CT imaging in the diagnosis of prostate cancer; | — |
Secondary
| Measure | Time frame |
|---|---|
| Differences in SUVmax and T/NT values between benign and malignant lesions; | — |
Countries
China
Contacts
Public ContactQiu Dasheng
Hubei Cancer Hospital
Outcome results
None listed